NEW STRATEGY FOR DRUG TREATMENT OF LUMINAL HER2-NEGATIVE METASTATIC BREAST CANCER
The article deals with the new oral target drug Palbociclib and its place in estrogen-receptor therapy, a positive HER2-negative metastatic breast cancer. Until recently, the consistent endocrine therapy was the primary treatment for the patients of this subgroup, as it significantly improved clinic...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Remedium Group LLC
2017-06-01
|
| Series: | Медицинский совет |
| Subjects: | |
| Online Access: | https://www.med-sovet.pro/jour/article/view/1884 |